Inhibition of proliferation and induction of apoptosis by melatonin in human myeloid HL‐60 cells
- 4 January 2007
- journal article
- Published by Wiley in Journal of Pineal Research
- Vol. 42 (2) , 131-138
Abstract
Abstract: Melatonin is an indoleamine that is synthesized in the pineal gland and has an extensive repertoire of biological activities. In the present study, we found that melatonin reduced the growth of the human myeloid leukemia cells HL‐60, inhibiting progression from G1 to S phase of the cell cycle and increasing apoptotic cell death. Furthermore, melatonin treatment elevated cytochrome c release from mitochondria and augmented caspase‐3 and caspase‐9 activities. Upregulation of Bax and downregulation of Bcl‐2 was also observed upon melatonin treatment. The effects of melatonin were found not to be mediated by membrane receptors for the indoleamine. Together, our results suggest that melatonin reduces the viability of HL‐60 cells via induction of apoptosis primarily through regulation of Bax/Bcl‐2 expression.Keywords
This publication has 43 references indexed in Scilit:
- Inhibitory effects of melatonin on the growth of pituitary prolactin‐secreting tumor in ratsJournal of Pineal Research, 2006
- Melatonin cytotoxicity in human leukemia cells: relation with its pro‐oxidant effectFundamental & Clinical Pharmacology, 2006
- Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activityInternational Journal of Cancer, 2005
- A role of melatonin in neuroectodermal‐mesodermal interactions: the hair follicle synthesizes melatonin and expresses functional melatonin receptorsThe FASEB Journal, 2005
- The victorin‐induced mitochondrial permeability transition precedes cell shrinkage and biochemical markers of cell death, and shrinkage occurs without loss of membrane integrityThe Plant Journal, 2004
- Cell DeathCell, 2004
- Melatonin in PlantsNutrition Reviews, 2001
- Randomized, double‐blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatmentJournal of Pineal Research, 2000
- Melatonin inhibits increase of intracellular calcium and cyclic AMP in neonatal rat pituitary via independent pathwaysMolecular and Cellular Endocrinology, 1995
- Antitumor Activity of the Pineal Gland: Effect of Unidentified Substances versus the Effect of MelatoninOncology, 1992